Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionality is currently unavailable.

Atsushi Fushimi, M.D.

Title
Institution
Department
Address
Phone

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Fushimi A, Takeyama H, Tachibana T, Manome Y. Osteogenic cocktail induces calcifications in human breast cancer cell line via placental alkaline phosphatase expression. Sci Rep. 2020 07 29; 10(1):12669. PMID: 32728117.
    Citations:    Fields:    
  2. Li W, Zhang N, Jin C, Long MD, Rajabi H, Yasumizu Y, Fushimi A, Yamashita N, Hagiwara M, Zheng R, Wang J, Kui L, Singh H, Kharbanda S, Hu Q, Liu S, Kufe D. MUC1-C drives stemness in progression of colitis to colorectal cancer. JCI Insight. 2020 Jun 18; 5(12). PMID: 32427590.
    Citations: 1     Fields:    
  3. Ishikawa Y, Tabei I, Fushimi A, Fuke A, Sekine C, Okamoto T, Takeyama H. Male breast metastasis of ureteral cancer: a case report. Surg Case Rep. 2020 Mar 30; 6(1):58. PMID: 32232598.
    Citations:    
  4. Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun. 2020 Feb 24; 11(1):1095. PMID: 32094369.
    Citations:    Fields:    
  5. Fushimi A, Tabei I, Fuke A, Okamoto T, Takeyama H. High-Dose Toremifene as a Promising Candidate Therapy for Hormone Receptor-Positive Metastatic Breast Cancer with Secondary Resistance to Aromatase Inhibitors. Int J Breast Cancer. 2020; 2020:7156574. PMID: 32099680.
    Citations:    
  6. Yasumizu Y, Rajabi H, Jin C, Hata T, Pitroda S, Long MD, Hagiwara M, Li W, Hu Q, Liu S, Yamashita N, Fushimi A, Kui L, Samur M, Yamamoto M, Zhang Y, Zhang N, Hong D, Maeda T, Kosaka T, Wong KK, Oya M, Kufe D. MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer. Nat Commun. 2020 01 17; 11(1):338. PMID: 31953400.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  7. Mimoto R, Yogosawa S, Saijo H, Fushimi A, Nogi H, Asakura T, Yoshida K, Takeyama H. Clinical implications of drug-screening assay for recurrent metastatic hormone receptor-positive, human epidermal receptor 2-negative breast cancer using conditionally reprogrammed cells. Sci Rep. 2019 09 16; 9(1):13405. PMID: 31527634.
    Citations: 1     Fields:    
  8. Hata T, Rajabi H, Takahashi H, Yasumizu Y, Li W, Jin C, Long MD, Hu Q, Liu S, Fushimi A, Yamashita N, Kui L, Hong D, Yamamoto M, Miyo M, Hiraki M, Maeda T, Suzuki Y, Samur MK, Kufe D. MUC1-C Activates the NuRD Complex to Drive Dedifferentiation of Triple-Negative Breast Cancer Cells. Cancer Res. 2019 11 15; 79(22):5711-5722. PMID: 31519689.
    Citations: 5     Fields:    Translation:HumansCells
  9. Fushimi A, Shinozaki N, Takeyama H. Hair regrowth using a properly fitted scalp cooling cap during adjuvant chemotherapy for breast cancer. Int Cancer Conf J. 2019 Oct; 8(4):181-184. PMID: 31559119.
    Citations:    
  10. Fushimi A, Kudo R, Takeyama H. Do Decreased Breast Microcalcifications After Neoadjuvant Chemotherapy Predict Pathologic Complete Response? Clin Breast Cancer. 2020 02; 20(1):e82-e88. PMID: 31255548.
    Citations:    Fields:    
  11. Fushimi A, Kinoshita S, Kudo R, Takeyama H. Incidental discovery of follicular lymphoma by sentinel lymph node biopsy and skin-sparing mastectomy for Paget's disease associated with invasive breast cancer. J Surg Case Rep. 2019 Jan; 2019(1):rjz008. PMID: 30697416.
    Citations:    
  12. Fushimi A, Fukushima N, Suzuki T, Kudo R, Takeyama H. Features of Microcalcifications on Screening Mammography in Young Women Asian Pac J Cancer Prev. 2018 Dec 25; 19(12):3591-3596. PMID: 30583687.
    Citations:    Fields:    Translation:Humans
  13. Fushimi A, Takeyama H, Manome Y. Effect of Heparin-Protamine Treatment on Thyroid Cancer Cell Lines. Anticancer Res. 2018 Dec; 38(12):6759-6762. PMID: 30504387.
    Citations:    Fields:    Translation:HumansCells
  14. Fushimi A, Yoshida A, Yagata H, Takahashi O, Hayashi N, Suzuki K, Tsunoda H, Nakamura S, Yamauchi H. Prognostic impact of multifocal and multicentric breast cancer versus unifocal breast cancer. Surg Today. 2019 Mar; 49(3):224-230. PMID: 30317491.
    Citations: 1     Fields:    Translation:Humans
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Fushimi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (67)
Explore
_
Co-Authors (7)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.